This 2019 photo provided by Civica Rx shows vials of vancomycin in Lehi, Utah. Impatient with years of inaction in Washington on prescription drug costs, U.S. hospital groups, startups and nonprofits have started making their own medicines in a bid to combat stubbornly high prices and persistent shortages of drugs with little competition. (Civica Rx via AP)

• January 12, 2024• In the News

Lawmakers: Maryland must expand reach of prescription drug board 

Baltimore Sun
Op-Ed
January 12, 2024

Excerpt:

“The (Maryland Prescription Drug Affordability) board will soon take a major step and announce upper payment limits for certain expensive drugs. This will help bring down drug costs for governments and save taxpayer dollars. It’s an important step forward in our campaign to make drugs more affordable.

But we must not stop there. Now it’s time to expand the board’s authority. In the 2024 legislative session in Annapolis, we will be working to authorize the board to implement similar upper payment limits for high-cost drugs for all Marylanders.”

Read the full op-ed from Senator Brian Feldman, Senator Dawn Gile, Delegate Bonnie Cullison and Delegate Jennifer White Holland, at the Baltimoresun.com

Last modified: January 12, 2024
← Previous Story: Health care legislation preview: Maryland advocates want to focus on access, patients in 2024 session
→ Next Story: With tight purse strings in Annapolis, health care advocates push for improved access to care, lower drug prices

Last modified: January 12, 2024

Comments are closed.

↑